Alexander Ngwube, MB,BS
Associate Professor
Department
Pediatrics (Phoenix)
Position
Associate Professor
Books
- Ngwube A., Unrelated donor hematopoietic stem cell transplantation for sickle cell disease 2017
Publications
- Transplantation and cellular therapy
Hans Rhea, Retrospective Analysis of Fresh Vs Cryopreserved Allogenic Bone Marrow Transplant within Pediatric Population: A Change in Practice Due to COVID-19 Pandemic
30:2, p. S246 - S246 2024 - Transplantation and cellular therapy
Rahim Mahvish Qureshi, Impact of CMV Reactivation on Clinical Outcomes Post Allogeneic Stem Cell Transplant in Patients with Sickle Cell Disease
30:2, p. S302 - S302 2024 - Transplantation and cellular therapy
Horan Fiona, Preservation of Pulmonary Function Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR Study
30:2, p. S45 - S46 2024 - Pediatrics (Evanston)
Booth Natalie, Reversal of Cerebral Arteriopathy Post-Hematopoietic Stem Cell Transplant for Sickle Cell Disease 2024 - Bone marrow transplantation (Basingstoke)
Gabelli Maria, Abatacept treatment for autoimmune hemolytic anemia occurring post hematopoietic stem cell transplantation 2023 - Blood
Stenger Elizabeth, Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study
142:Supplement 1, p. 4955 - 4955 2023 - Blood
Ngwube Alexander I., Abatacept-Prophylaxis Based Haploidentical Transplantation May Allow Sustained Engraftment and Offset Gvhd in Non-Malignant Disorders
142:Supplement 1, p. 4901 - 4901 2023 - Blood
John Tami D., Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study
142:Supplement 1, p. 4904 - 4904 2023 - Blood
Shah Niketa C., Outcomes after RIC and Abatacept-Based Acute and Chronic Gvhd Prophylaxis in Allogeneic Transplantation for Sickle Cell Disease - Can Calcineurin Inhibitor Use be Curtailed?
142:Supplement 1, p. 2185 - 2185 2023 - Current opinion in hematology
Shah Niketa C., Mixed donor chimerism following stem cell transplantation for sickle cell disease 2023 - Transplantation and cellular therapy
Booth Natalie, Efficacy of Azacitidine and Prophylactic Donor Lymphocyte Infusion after HSCT in Pediatric Patients with Acute Myelogenous Leukemia: A Retrospective Pre-Post Study
29:5, p. 330.e1 - 330.e7 2023 - Transplantation and cellular therapy
Guilcher Gregory MT, 391 - Clinical Outcomes and Long-Term Follow-up of Children with Mixed Myeloid Chimerism Following Hematopoietic Cell Transplantation (HCT) for Sickle Cell Disease (SCD)
29:2, p. S296 - S297 2023 - Transplantation and cellular therapy
Kasow Kimberly A., 387 - Curing Children with Sickle Hemoglobinopathies of Varying Severity Early in Life with HLA-Matched Sibling Donor (MSD) Hematopoietic Cell Transplantation (HCT) Following a Reduced Intensity Conditioning (RIC) Regimen: A Sickle Transplant, Advocacy, a
29:2, p. S293 - S294 2023 - Pediatric Blood and Cancer
Shah A., Investigating racial disparities in quality-of-life years after pediatric hematopoietic stem cell transplant
70:9 2023 - Therapeutic Advances in Hematology
Ngwube A., Role of abatacept in the prevention of graft-versus-host disease: current perspectives
14 2023 - Pediatric Hematology and Oncology
Ngwube A., Pre-hematopoietic stem cell transplantation lung computed tomography is not an alternative to PFT for pediatric patients with sickle cell disease 2023 - JCO Precision Oncology
Goode E., Diagnostic and Prognostic Implications of GNAS Inactivation in Sonic Hedgehog-Activated Medulloblastoma: Case Report with Comprehensive Molecular Profiling and Review of Literature
6 2022 - Pediatric Hematology and Oncology
Goode E., Busulfan-based reduced toxicity conditioning regimen used in hematopoietic stem cell transplantation in HLH patients results in sustained donor chimerism
38:4 2021 - Transfusion
Nizzi F., Successful management of sirolimus toxicity in a hematopoietic stem cell transplant patient using automated red blood cell exchange
60:12 2020 - Journal of Pediatric Hematology/Oncology
Hickman K., Dasatinib-induced Chylothorax in Chronic Myelogenous Leukemia in Pediatric Patient: Report of a Case and Review of Literature
42:7 2020 - Pediatric Hematology and Oncology
Huschart E., Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia
38:2 2020 - Transfusion
Hess J., Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept
58:9 2018 - Biology of Blood and Marrow Transplantation
Ngwube A., Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
24:3 2018 - Pediatric Blood and Cancer
Beebe K., Vitamin D deficiency and outcomes in pediatric hematopoietic stem cell transplantation
65:2 2018 - Journal of Pediatric Hematology/Oncology
Madden L.M., Late toxicity of a novel allogeneic stem cell transplant using single fraction total body irradiation for hematologic malignancies in children
37:2 2015 - Pediatric Blood and Cancer
Ngwube A., Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia
62:7 2015 - Journal of Clinical Rheumatology
Kitcharoensakkul M., Scurvy revealed by difficulty walking: Three cases in young children
20:4 2014 - Clinical Pediatrics
Ngwube A., Disseminated Salmonella osetomyelitis in a 2-year-old with sickle cell disease
51:6 2012